chlorthalidone 12.5 MG Oral Tablet [Hemiclor]

RxCUI
2709679
RxNorm name
chlorthalidone 12.5 MG Oral Tablet [Hemiclor]
Display name
chlorthalidone 12.5 MG Oral Tablet [Hemiclor]
Full name
chlorthalidone 12.5 MG Oral Tablet [Hemiclor]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:55

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
HEMICLORCHLORTHALIDONEIngenus Pharmaceuticals, LLC3f0f3ee0-f5a6-4bda-8160-a77744e9fa462025-03-27Warnings, Adverse reactionsExact identifier
rxcui: 2709679

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
3f0f3ee0-f5a6-4bda-8160-a77744e9fa46chlorthalidone 12.5 MG Oral Tablet [Hemiclor]SBD1These highlights do not include all the information needed to use HEMICLOR TM safely and effectively. See full prescribing information for HEMICLOR. HEMICLOR (chlorthalidone) tablets, for oral use Initial U.S. Approval: 196020250327
3f0f3ee0-f5a6-4bda-8160-a77744e9fa46Hemiclor 12.5 MG Oral TabletSY1These highlights do not include all the information needed to use HEMICLOR TM safely and effectively. See full prescribing information for HEMICLOR. HEMICLOR (chlorthalidone) tablets, for oral use Initial U.S. Approval: 196020250327
3f0f3ee0-f5a6-4bda-8160-a77744e9fa46Hemiclor 12.5 MG Oral TabletPSN1These highlights do not include all the information needed to use HEMICLOR TM safely and effectively. See full prescribing information for HEMICLOR. HEMICLOR (chlorthalidone) tablets, for oral use Initial U.S. Approval: 196020250327